Concurrent Treatment of Substance Abuse and Child Maltreatment

May 11, 2021 updated by: Ron Prinz, PhD, University of South Carolina
The co-occurrence of child maltreatment and parental substance-use problems is a major public health problem with serious consequences for children, parents, families, and the community at large. The need for effective dual treatment of caregiver substance abuse and child maltreatment is unquestionable, but there is a dearth of controlled treatment outcome studies with substance-using parents who have engaged in child maltreatment. This project examines two evidence-based treatments-Contingency Management for substance-use problems and Pathways Triple P parenting intervention to improve parenting for prevention of child-maltreatment recurrence. These two systematic interventions are being tested in the context of traditional outpatient treatment for substance-use problems.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Study Type

Interventional

Enrollment (Actual)

200

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • United States
    • South Carolina
      • Columbia, South Carolina, United States, 29208
        • University of South Carolina Parenting & Family Res Center

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • open child protective services case for child maltreatment
  • beginning intensive outpatient treatment for drug or alcohol use problem
  • at least one child 2-8 years of age

Exclusion Criteria:

  • not primary custodial parent for child 2-8 years of age
  • serious mental illness
  • residing outside the two participating counties

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Factorial Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Treatment as Usual (TAU)
Outpatient substance-abuse treatment plus drug and alcohol screening plus brief support for personal goal setting
Behavioral: Treatment as usual (TAU)
Outpatient substance-abuse therapy plus drug & alcohol screening plus support for personal goal setting
Experimental: Contingency Management
Contingency management for drug and alcohol abstinence plus TAU
Behavioral: Treatment as usual (TAU)
Outpatient substance-abuse therapy plus drug & alcohol screening plus support for personal goal setting
Behavioral: Reinforcement for drug & alcohol abstinence
Other Names:
  • Contingency management for negative drug & alcohol samples
Experimental: Parenting Intervention
Parenting intervention plus TAU
Behavioral: Treatment as usual (TAU)
Outpatient substance-abuse therapy plus drug & alcohol screening plus support for personal goal setting
Behavioral: Parenting intervention
Other Names:
  • Pathways Triple P
Experimental: Parenting Intervention + Contingency Management
Parenting intervention plus contingency management for drug and alcohol abstinence plus TAU
Behavioral: Treatment as usual (TAU)
Outpatient substance-abuse therapy plus drug & alcohol screening plus support for personal goal setting
Behavioral: Reinforcement for drug & alcohol abstinence
Other Names:
  • Contingency management for negative drug & alcohol samples
Behavioral: Parenting intervention
Other Names:
  • Pathways Triple P

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
longest duration of negative urine and breath samples
Time Frame: 13 weeks
13 weeks
recurrence of child maltreatment--child protective services records
Time Frame: 18 months after baseline
18 months after baseline

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
self-reported substance use--Addiction Severity Index-Lite
Time Frame: 4 months after baseline; 12 months after baseline; 18 months after baseline
Drug and Alcohol Composite (severity)
4 months after baseline; 12 months after baseline; 18 months after baseline
parent report of child behavior problems--child behavior inventory
Time Frame: 4 months after baseline; 12 months after baseline; 18 months after baseline
Intensity score for child behavior problems
4 months after baseline; 12 months after baseline; 18 months after baseline
self-reported parenting--Parenting Scale; Parenting Practices Interview
Time Frame: 4 months after baseline; 12 months after baseline; 18 months after baseline
Parenting Scale: Overreactivity; Laxness Parenting Practices Interview: Appropriate Discipline; Harsh and Inconsistent Discipline
4 months after baseline; 12 months after baseline; 18 months after baseline

Other Outcome Measures

Outcome Measure
Time Frame
self-reported quality of life--Quality of Life Inventory
Time Frame: 4 months after baseline; 12 months after baseline; 18 months after baseline
4 months after baseline; 12 months after baseline; 18 months after baseline
self-reported HIV behavioral risk--HIV Risk Behavior Scale
Time Frame: 4 months after baseline; 12 months after baseline; 18 months after baseline
4 months after baseline; 12 months after baseline; 18 months after baseline

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

University of South Carolina

Investigators

  • Principal Investigator: Ron Prinz, Ph.D., University of South Carolina

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

April 1, 2013

Primary Completion (Actual)

December 31, 2019

Study Completion (Actual)

January 31, 2020

Study Registration Dates

First Submitted

May 10, 2016

First Submitted That Met QC Criteria

May 12, 2016

First Posted (Estimate)

May 17, 2016

Study Record Updates

Last Update Posted (Actual)

May 12, 2021

Last Update Submitted That Met QC Criteria

May 11, 2021

Last Verified

May 1, 2021

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • Pro00015175

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Substance Use

Clinical Trials on Treatment as usual (TAU)

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Dominican Republic

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

3
Subscribe